UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy

Oncogene, 2016-05, Vol.35 (20), p.2547-2561

2016

Volltextzugriff (PDF)

The role of Plk3 in oncogenesis

Oncogene, 2016-01, Vol.35 (2), p.135-147

2016

Volltextzugriff (PDF)

Effect of RNA Silencing of Polo-Like Kinase-1 (PLK1) on Apoptosis and Spindle Formation in Human Cancer Cells

JNCI : Journal of the National Cancer Institute, 2002-12, Vol.94 (24), p.1863-1877

2002

Volltextzugriff (PDF)

Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo

Oncogene, 2006-03, Vol.25 (12), p.1753-1762

2006

Volltextzugriff (PDF)

Cancer Inhibition in Nude Mice After Systemic Application of U6 Promoter–Driven Short Hairpin RNAs Against PLK1

JNCI : Journal of the National Cancer Institute, 2004-06, Vol.96 (11), p.862-872

2004

Volltextzugriff (PDF)

Rational combinations of siRNAs targeting Plk1 with breast cancer drugs

Oncogene, 2007-08, Vol.26 (39), p.5793-5807

2007

Volltextzugriff (PDF)

Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus

Oncogene, 2017-11, Vol.36 (48), p.6712-6724

2017

Volltextzugriff (PDF)

Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16 18-infected cancer cells

Oncogene, 2010-10, Vol.29 (41), p.5591-5603

2010

Volltextzugriff (PDF)

Combinatorial application of nucleic acid-based agents targeting protein kinases for cancer treatment

Current pharmaceutical design, 2008-04, Vol.14 (11), p.1098-1112

2008

Volltextzugriff (PDF)

The role of early expression of inducible nitric oxide synthase in human breast cancer

European journal of cancer (1990), 2005, Vol.41 (2), p.265-271

2005

Volltextzugriff (PDF)

Polo-like kinases and oncogenesis

Oncogene, 2005-01, Vol.24 (2), p.267-276

2005

Volltextzugriff (PDF)

1003 The role of DAPK1 in the cell cycle regulation of cervical cancer cells and in response to topotecan

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A338-A339

2021

Volltextzugriff (PDF)

RNA interference-based gene silencing in mice: the development of a novel therapeutical strategy

Current pharmaceutical design, 2005-01, Vol.11 (26), p.3405-3419

2005

Volltextzugriff (PDF)

Induction and Down-Regulation of PLK, a Human Serine/Threonine Kinase Expressed in Proliferating Cells and Tumors

Proceedings of the National Academy of Sciences - PNAS, 1994-03, Vol.91 (5), p.1736-1740

1994

Volltextzugriff (PDF)

Effect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturation

Biomaterials, 2008-10, Vol.29 (29), p.4022-4028

2008

Volltextzugriff (PDF)

Polo-like kinase, a novel marker for cellular proliferation

The American journal of pathology, 1997-04, Vol.150 (4), p.1165-1172

1997

Volltextzugriff (PDF)

Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells

Oncogene, 2004-07, Vol.23 (34), p.5843-5852

2004

Volltextzugriff (PDF)

Pre-treatment haemoglobin level predicts response and survival after TPF induction polychemotherapy in advanced head and neck cancer patients

Clinical otolaryngology, 2008-06, Vol.33 (3), p.245-251

2008

Volltextzugriff (PDF)

T Cell Receptor “Inside-Out” Pathway via Signaling Module SKAP1-RapL Regulates T Cell Motility and Interactions in Lymph Nodes

Immunity (Cambridge, Mass.), 2010-04, Vol.32 (4), p.541-556

2010

Volltextzugriff (PDF)

Tumour cell delivery of antisense oligonucleotides by human serum albumin nanoparticles

Journal of controlled release, 2004-05, Vol.96 (3), p.483-495

2004

Volltextzugriff (PDF)

Investigations on the inducible and endothelial nitric oxide synthases in human breast cancer cell line MCF-7 – estrogen has an influence on e-NOS, but not on i-NOS

Pathology, research and practice, 2006-01, Vol.202 (1), p.1-7

2006

Volltextzugriff (PDF)

Targeting the G2/M Transition for Antitumor Therapy

Letters in drug design & discovery, 2005-06, Vol.2 (4), p.274-281

2005

Volltextzugriff (PDF)

OC-0150: Assessing the immune contexture of anal squamous cell carcinoma

Radiotherapy and oncology, 2018-04, Vol.127, p.S75-S76

2018

Volltextzugriff (PDF)

Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells

Journal of drug targeting, 2004-01, Vol.12 (7), p.461-471

2004

Volltextzugriff (PDF)

The Biological Relevance of FHL2 in Tumour Cells and its Role as a Putative Cancer Target

Anticancer research, 2007-01, Vol.27 (1A), p.55-61

2007

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(88)
Tagungsberichte
(8)

Sprache

Englisch
(83)
Japanisch
(18)
Deutsch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Life Sciences & Biomedicine
(60)
Humans
(59)
Biological And Medical Sciences
(37)
Oncology
(37)
Biochemistry & Molecular Biology
(26)
Animals
(25)
Polo-Like Kinase 1
(21)
Medical Sciences
(20)
Cell Biology
(19)
Genetics & Heredity
(19)
Fundamental And Applied Biological Sciences. Psychology
(18)
Female
(17)
Tumors
(17)
Base Sequence
(14)
Molecular And Cellular Biology
(14)
Molecular Sequence Data
(14)
Cell Cycle Proteins
(13)
Protein Serine-Threonine Kinases
(13)
Proto-Oncogene Proteins
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy

The role of Plk3 in oncogenesis

Effect of RNA Silencing of Polo-Like Kinase-1 (PLK1) on Apoptosis and Spindle Formation in Human Cancer Cells

Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo

Cancer Inhibition in Nude Mice After Systemic Application of U6 Promoter–Driven Short Hairpin RNAs Against PLK1

Rational combinations of siRNAs targeting Plk1 with breast cancer drugs

Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus

Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16 18-infected cancer cells

Combinatorial application of nucleic acid-based agents targeting protein kinases for cancer treatment

The role of early expression of inducible nitric oxide synthase in human breast cancer

Polo-like kinases and oncogenesis

1003 The role of DAPK1 in the cell cycle regulation of cervical cancer cells and in response to topotecan

RNA interference-based gene silencing in mice: the development of a novel therapeutical strategy

Induction and Down-Regulation of PLK, a Human Serine/Threonine Kinase Expressed in Proliferating Cells and Tumors

Effect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturation

Polo-like kinase, a novel marker for cellular proliferation

Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells

Pre-treatment haemoglobin level predicts response and survival after TPF induction polychemotherapy in advanced head and neck cancer patients

T Cell Receptor “Inside-Out” Pathway via Signaling Module SKAP1-RapL Regulates T Cell Motility and Interactions in Lymph Nodes

Tumour cell delivery of antisense oligonucleotides by human serum albumin nanoparticles

Investigations on the inducible and endothelial nitric oxide synthases in human breast cancer cell line MCF-7 – estrogen has an influence on e-NOS, but not on i-NOS

Targeting the G2/M Transition for Antitumor Therapy

OC-0150: Assessing the immune contexture of anal squamous cell carcinoma

Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells

The Biological Relevance of FHL2 in Tumour Cells and its Role as a Putative Cancer Target

Suchergebnisse filtern